Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Market Cap | 386.019 Million | Shares Outstanding | 65.649 Million | Avg 30-day Volume | 166.606 Thousand |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -0.63 |
Price to Revenue | 0.0 | Debt to Equity | 0.0 | EBITDA | -84.711 Million |
Price to Book Value | 0.953 | Operating Margin | 0.0 | Enterprise Value | 15.209 Million |
Current Ratio | 12.856 | EPS Growth | 0.959 | Quick Ratio | 12.256 |
1 Yr BETA | 1.1311 | 52-week High/Low | 7.57 / 3.48 | Profit Margin | 0.0 |
Operating Cash Flow Growth | -29.4427 | Altman Z-Score | -0.0658 | Free Cash Flow to Firm | -76.577 Million |
Please sign in first
none
none
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
ANG ROBERT PRESIDENT AND CEO |
|
700,665 | 2023-03-01 | 3 |
CHAKRABORTY TIRTHA CHIEF SCIENTIFIC OFFICER |
|
142,154 | 2023-03-01 | 3 |
JORGENSEN NATHAN D. CHIEF FINANCIAL OFFICER |
|
154,459 | 2023-03-01 | 3 |
ATTAR EYAL C. CHIEF MEDICAL OFFICER |
|
54,500 | 2023-02-06 | 3 |
|
22,748,880 | 2022-12-09 | 2 | |
|
16,911 | 2022-06-14 | 1 | |
|
16,911 | 2022-06-14 | 1 | |
|
16,911 | 2022-06-14 | 1 | |
|
16,911 | 2022-06-14 | 1 | |
|
16,911 | 2022-06-14 | 1 | |
|
16,911 | 2022-06-14 | 1 | |
SLAPAK CHRISTOPHER CHIEF MEDICAL OFFICER |
|
116,000 | 2022-02-01 | 0 |
|
6,361,723 | 2021-11-16 | 0 | |
|
No longer subject to file | 2021-02-09 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-03-02 18:35:49 -0500 | 2023-03-01 | F | 6,310 | $5.51 | d | 154,459 | direct | 0.0 | -10.5163 | 4.2065 | 3 | -10.5163 | 6 | |||
2023-03-02 18:37:48 -0500 | 2023-03-01 | F | 5,576 | $5.51 | d | 142,154 | direct | 0.0 | -10.5163 | 4.2065 | 3 | -10.5163 | 6 | |||
2023-03-02 18:39:46 -0500 | 2023-03-01 | F | 12,657 | $5.51 | d | 700,665 | direct | 0.0 | -10.5163 | 4.2065 | 3 | -10.5163 | 6 | |||
2023-02-08 16:18:12 -0500 | 2023-02-06 | A | 47,750 | a | 147,730 | direct | 2.7829 | -0.7421 | 9.0909 | 13.7291 | 10 | -13.1725 | 21 | |||
2023-02-08 16:18:12 -0500 | 2023-02-06 | A | 95,500 | a | 95,500 | direct | ||||||||||
2023-02-08 16:23:55 -0500 | 2023-02-06 | A | 54,500 | a | 54,500 | direct | 2.7829 | -0.7421 | 9.0909 | 13.7291 | 10 | -13.1725 | 21 | |||
2023-02-08 16:23:55 -0500 | 2023-02-06 | A | 109,000 | a | 109,000 | direct | ||||||||||
2023-02-08 16:22:04 -0500 | 2023-02-06 | A | 45,500 | a | 160,769 | direct | 2.7829 | -0.7421 | 9.0909 | 13.7291 | 10 | -13.1725 | 21 | |||
2023-02-08 16:22:04 -0500 | 2023-02-06 | A | 91,000 | a | 91,000 | direct | ||||||||||
2023-02-08 16:28:04 -0500 | 2023-02-06 | A | 128,750 | a | 713,322 | direct | 2.7829 | -0.7421 | 9.0909 | 13.7291 | 10 | -13.1725 | 21 | |||
2023-02-08 16:28:04 -0500 | 2023-02-06 | A | 257,500 | a | 257,500 | direct |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
VOR BIOPHARMA INC VOR | 2023-03-24 22:15:03 UTC | 2.0349 | 2.7851 | 100000 |
VOR BIOPHARMA INC VOR | 2023-03-24 21:45:03 UTC | 2.0349 | 2.7851 | 100000 |
VOR BIOPHARMA INC VOR | 2023-03-24 21:15:03 UTC | 2.0349 | 2.7851 | 100000 |
VOR BIOPHARMA INC VOR | 2023-03-24 20:45:03 UTC | 2.0349 | 2.7851 | 100000 |
VOR BIOPHARMA INC VOR | 2023-03-24 20:15:04 UTC | 2.0349 | 2.7851 | 100000 |
VOR BIOPHARMA INC VOR | 2023-03-24 19:45:03 UTC | 2.0349 | 2.7851 | 100000 |
VOR BIOPHARMA INC VOR | 2023-03-24 19:15:04 UTC | 2.0349 | 2.7851 | 100000 |
VOR BIOPHARMA INC VOR | 2023-03-24 18:45:04 UTC | 2.0349 | 2.7851 | 100000 |
VOR BIOPHARMA INC VOR | 2023-03-24 18:15:03 UTC | 2.0349 | 2.7851 | 100000 |
VOR BIOPHARMA INC VOR | 2023-03-24 17:45:03 UTC | 2.0349 | 2.7851 | 100000 |
VOR BIOPHARMA INC VOR | 2023-03-24 17:15:03 UTC | 2.0349 | 2.7851 | 100000 |
VOR BIOPHARMA INC VOR | 2023-03-24 16:45:03 UTC | 2.0383 | 2.7817 | 100000 |
VOR BIOPHARMA INC VOR | 2023-03-24 16:15:03 UTC | 2.0383 | 2.7817 | 100000 |
VOR BIOPHARMA INC VOR | 2023-03-24 15:45:03 UTC | 2.0383 | 2.7817 | 100000 |
VOR BIOPHARMA INC VOR | 2023-03-24 15:15:03 UTC | 2.0383 | 2.7817 | 100000 |
VOR BIOPHARMA INC VOR | 2023-03-24 14:45:03 UTC | 2.0383 | 2.7817 | 100000 |
VOR BIOPHARMA INC VOR | 2023-03-24 14:15:03 UTC | 2.0383 | 2.7817 | 80000 |
VOR BIOPHARMA INC VOR | 2023-03-24 13:45:03 UTC | 2.092 | 2.478 | 80000 |
VOR BIOPHARMA INC VOR | 2023-03-24 13:15:04 UTC | 2.092 | 2.478 | 65000 |
VOR BIOPHARMA INC VOR | 2023-03-24 12:45:03 UTC | 2.092 | 2.478 | 60000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|---|---|---|---|
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund | VOR | -1300.0 shares, $-8645.0 | 2022-12-31 | N-PORT |
RUSSELL INVESTMENT FUNDS- U.S. Small Cap Equity Fund | VOR | -964.0 shares, $-6410.6 | 2022-12-31 | N-PORT |